In the Lilly-funded trial, 31% on the 12 mg dose lost a quarter of their weight, and researchers reported better blood sugar plus lower inflammation markers.
Recap by typeshit. Full story at UNILAD.
Centre Daily Times looks at how peptides taken by mouth can get past the gut intact and reach specific spots in the body, a key hurdle for pill versions of these drugs.
18:20
Dr. Lindsay Ogle, an MD who covers metabolic health, talks through options for people whose appetite hasn't settled on GLP-1 treatment.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
The scale went up roughly 2.5 pounds since the last check-in, but the poster says life on tirzepatide is going well overall.
ScienceAlert reports the rate among people who never took the drugs was 9%, a gap researchers say is worth investigating further.
Loading…